Dihydrolipoamide dehydrogenase deficiency in five siblings with variable phenotypes, including fulminant fatal liver failure despite good engraftment of transplanted liver

Gespeichert in:
Bibliographische Detailangaben
Titel: Dihydrolipoamide dehydrogenase deficiency in five siblings with variable phenotypes, including fulminant fatal liver failure despite good engraftment of transplanted liver
Autoren: Mihaela Mihaljević, Danijela Petković Ramadža, Tamara Žigman, Ivana Rako, Slobodan Galić, Toni Matić, Filip Rubić, Ivana Čulo Čagalj, Davor Mayer, Ante Gojević, Stanko Ćavar, Marijana Ćorić, Melanie T. Achleitner, Johannes A. Mayr, Ksenija Fumić, Jurica Vuković, Ivo Barić
Quelle: JIMD Reports, Vol 65, Iss 5, Pp 323-329 (2024)
Verlagsinformationen: Wiley, 2024.
Publikationsjahr: 2024
Bestand: LCC:Diseases of the endocrine glands. Clinical endocrinology
LCC:Genetics
Schlagwörter: dihydrolipoamide dehydrogenase deficiency, fulminant liver failure, liver transplant, riboflavin responsiveness, Diseases of the endocrine glands. Clinical endocrinology, RC648-665, Genetics, QH426-470
Beschreibung: Abstract Dihydrolipoamide dehydrogenase (DLD) deficiency can, in one of its forms, be a rare cause of acute liver failure. Clinical presentation is nonspecific. Biochemical findings can reflect metabolic block, but vary depending on patient and his condition. Consensus treatment guidelines do not exist. We present a family with five members suffering from DLD deficiency. Patient 1 presented with emesis, mental deterioration, and fulminant hepatic failure, which required high‐urgency liver transplantation. His younger brother, patient 2, experienced unexplained hypoglycemia and metabolic acidosis on the second day after cardiac surgery. Three affected younger siblings were asymptomatic. In patients with acute liver failure of unknown etiology urgent metabolic work‐up should be done, and whole exome sequencing considered. Liver transplantation remains life‐saving treatment option, but its outcome may be dependent on etiology‐specific supportive treatment.
Publikationsart: article
Dateibeschreibung: electronic resource
Sprache: English
ISSN: 2192-8312
Relation: https://doaj.org/toc/2192-8312
DOI: 10.1002/jmd2.12444
Zugangs-URL: https://doaj.org/article/6a408d88d75b46949de9c20df4a09d5b
Dokumentencode: edsdoj.6a408d88d75b46949de9c20df4a09d5b
Datenbank: Directory of Open Access Journals
Beschreibung
Abstract:Abstract Dihydrolipoamide dehydrogenase (DLD) deficiency can, in one of its forms, be a rare cause of acute liver failure. Clinical presentation is nonspecific. Biochemical findings can reflect metabolic block, but vary depending on patient and his condition. Consensus treatment guidelines do not exist. We present a family with five members suffering from DLD deficiency. Patient 1 presented with emesis, mental deterioration, and fulminant hepatic failure, which required high‐urgency liver transplantation. His younger brother, patient 2, experienced unexplained hypoglycemia and metabolic acidosis on the second day after cardiac surgery. Three affected younger siblings were asymptomatic. In patients with acute liver failure of unknown etiology urgent metabolic work‐up should be done, and whole exome sequencing considered. Liver transplantation remains life‐saving treatment option, but its outcome may be dependent on etiology‐specific supportive treatment.
ISSN:21928312
DOI:10.1002/jmd2.12444